AzTrials
AzTrials

InsomniaNCT04306835

The Impact of CBT-i on CPAP Therapy Use and Drop Outs in OSAS Patients With Insomnia.

A study testing Cognitive behavioural therapy for insomnia in people with Insomnia and Obstructive Sleep Apnea, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Patients follow the fully standard sleep test according to the normal procedure. This means that they undergo a polysomnography and fill in a questionnaire. If according to the questionnaire, there is insomnia, the patient also receives an intake interview to check whether this is indeed the case. Read more about this study

Who is it for?
Ages 18 to 75 years
What is being tested?
Cognitive behavioural therapy for insomnia
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteBelgium
Study dates
22 Oct 2018to Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All patients, male and female, with an OSAS diagnosed by full polysomnography and insomnia diagnosed by questionnaires.
  • Age between 18 and 75 years
  • Dutch as native language

Who cannot join

  • Patients younger than 18 years and older than 75 years
  • Patients with a burn-out
  • Patients with restless legs
  • Pregnant woman
  • Patients who work as shift workers
  • Patients with severe psychiatric disorder
  • Patients who take sleep medication, unless it can be reduced and stopped during cognitive behavior therapy
  • Patients with daily alcohol abuse (men > 3 drinks on any day or 14 per week, women > 2 drinks on any day or 7 per week)

Trial locations and contacts

1 site in 1 country.

Jasper Molenberghs contact

0494182014

jasper.molenberghs@vub.be

Belgium1 site, 1 recruiting
  • UZ Brussel

    Jette, Brussels Capital, 1050

    Sonia De Weerdt, 024773890, sonia.deweerdt@uzbrussel.be

    Recruiting

Other trials in Belgium

About this study

Official title: The Impact of Cognitive Behavioral Therapy for Insomnia on CPAP Therapy Use and Drop Outs in Obstructive Sleep Apnea Syndrome Patients With Insomnia.

Patients follow the fully standard sleep test according to the normal procedure. This means that they undergo a polysomnography and fill in a questionnaire. If according to the questionnaire, there is insomnia, the patient also receives an intake interview to check whether this is indeed the case. If the patient has both disorders and meets the inclusion and exclusion criteria, they will be asked to sign the informed consent. If the patient agrees, the CPAP-therapy will be started as usual, simultaneously with CGT-i. The latter will last 7 weeks and will cover the following points: psycho-education, sleep restriction and sleep hygiene, cognition, relaxation and relapse prevention. Because of the design of this study (starting CGT-I as soon as possible after the diagnosis of OSAS) and the groups already planned for CBT-I, it is not possible for all participants to participate in group cognitive behavioral therapy, therefore individual sessions were provided for these participants. The patient comes for monitoring at set times.

Being tested
Cognitive behavioural therapy for insomnia
Medical subject headings
Sleep Initiation and Maintenance Disorders, Sleep Apnea, Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive behavioural therapy for insomniaBehavioural

    a technique for treating insomnia without medications

Study groups in NCT04306835
Study groupRoleWhat they receive
CPAP + CBT-iActive comparatorPatients treated simultaneously with CPAP for their OSAS and cognitive behavioral therapy for their insomnia.
Receives: Behavioral: Cognitive behavioural therapy for insomnia
CPAP onlyNo interventionPatients suffering from OSAS and insomnia, but only treated with CPAP.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The number of drop-outs in patients participating in the study.

    Patiënt who don't use there CPAP anymore.

    Measured: 12 weeks

  2. CPAP habituation in patients participating in the study.

    The speed of CPAP habituation is determined by reading the CPAP device.

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Mar 2020
  2. Study start22 Oct 2018
  3. Primary completionMar 2020 (estimated)
  4. Study completionMar 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04306835
Sponsor's protocol ID
143201836242
Status last verified
Mar 2019
First submitted
27 Feb 2020
Last updated
13 Mar 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive behavioural therapy for insomnia in people with Insomnia and Obstructive Sleep Apnea, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jasper Molenberghs (0494182014, jasper.molenberghs@vub.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The number of drop-outs in patients participating in the study. (time frame: 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in